The initiation of the Phase 1/2a clinical trial will represent a key milestone in advancing a first-in-class HMGB1-targeted immunomodulatory antibody for patients with frontotemporal lobar ...

Outsource high-potency ADC manufacturing to specialized CDMOs to reduce capital investment, access containment infrastructure, and accelerate clinical-to-commercial scale-up.Dublin, Oct. (GLOBE ...

Samsung Biologics touts end-to-end ADC CDMO services at World ADC San Diego Third straight year with a solo booth as it ...

CDMO giant Samsung Biologics and LegoChem Biosciences are joining forces to develop and manufacture antibody-drug conjugates. (Marcin Klapczynski/Getty Images) Samsung Biologics signed a partnership ...

DURHAM, N.C.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), announces a manufacturing contract ...

SEOUL, April 1 (Yonhap) -- Lotte Biologics Co., the biotech arm of Lotte Group, said Wednesday it has signed a contract with a U.S.-based oncology biotech company to produce antibody drug substance.

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), ("Scinai" or the "Company"), a biopharmaceutical company combining innovative ...

Esteve CDMO, the contract development and manufacturing organization within Spanish specialty pharma Esteve, is overhauling ...

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. The "Antibody Contract Development & Manufacturing ...

Samsung Biologics showcased its end-to-end contract development and manufacturing capabilities at the world's largest ...